SELP and cancer: Platelet count, leukocyte count, hemoglobin, d-dimer, tissue factor, soluble P-selectin, factor VIII, and prothrombin fragment F 1+2 are potential biomarkers that may be predictive of vein thromboembolism in cancer [10–12].